|
WO2020223523A1
|
|
Alpha-synuclein assays
|
|
WO2020139571A1
|
|
Domperidone compositions and methods for treating depression
|
|
WO2020139520A1
|
|
Domperidone antineurodegenerative combinations and use
|
|
WO2020068913A1
|
|
Anti-neurodegenerative combinations and use for treatment of neurodegenerative diseases
|
|
WO2020068832A1
|
|
Composition and use for the treatment of parkinson's disease and related disorders
|
|
US2020400687A1
|
|
Methods for developing pharmaceuticals for treating neurodegenerative conditions
|
|
CN111093647A
|
|
Statin compositions and methods for treating synucleinopathies
|
|
CN111032158A
|
|
NK-1 antagonist compositions and methods for treating depression
|
|
AU2018271895A1
|
|
Pharmaceutical combinations of zonisamide and praxipexole, and related methods, for treating synucleinopathies
|
|
BR112019022175A2
|
|
COMPOSITIONS AND METHOD FOR DEPRESSION TREATMENT
|
|
US2020375956A1
|
|
Pharmaceutical combination and its use for treating synucleinopathies
|
|
KR20200002899A
|
|
NK1-antagonist combinations and methods for treating synuclein lesions
|
|
BR112019020100A2
|
|
compositions and methods for treating synucleinopathies
|
